SERUM FERRITIN, ALPHA2 H GLOBULIN AND MALIGNANT DISEASE
SIR,-There is already a considerable literature relating to the significance of specific circulating proteins in various types of malignant disease. We should like to draw attention to the confusion that can arise when a specific antigen is given a different name by different groups of workers. In 1973 we reported in your Journal that patients with acute leukaemia and Hodgkin's disease had raised serum concentrations of ferritin (Jones et al., 1973) and since that time studies in acute leukaemia have shown increased synthesis of the protein by leukaemic cells (White et al., 1974) . A recent review (British Medical Journal, 1975) refers to the subject of alpha2 H globulin in cancer surveillance and once again we have noted the close similarities between the studies on this protein by Buffe and her colleagues (1972) and our own investigations into " serum ferritin " .
Alpha2 H globulin appears to share many properties with the iron containing protein ferritin. It has a molecular weight of about 600,000, normally contains 15-25% iron but can occur without iron (Buffe et al., 1972 (Worwood, Dawkins and Jacobs, 1975) . Circulating ferritin appears to differ from normal liver or spleen ferritin in a number of ways including its iron content .
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On cellulose acetate electrophoresis in barbitone buffer at pH 8-6 purified human liver ferritin moves similarly to the alpha2 component of serum proteins (see Figure) . There are a number of other similarities. Alpha2 H globulin extracted from tumour or from foetal liver appears to differ from that extracted from normal liver in carbohydrate content, iron content and state of polymerization (Rimbaut, 1973) . Similarly, differences occur between ferritin preparations from normal and malignant or foetal tissue (Harrison et al., 1974) . Both serum ferritin and alpha2 H globulin concentrations are increased in patients with hepatoma or acute lymphoblastic leukaemia. A rise in alpha2 H globulin concentration precedes relapse in children with hepatoma who have undergone chemotherapy (Rimbaut, 1973) and serum ferritin concentrations may give a similar warning in children with acute lymphoblastic leukaemia (Parry, Worwood and Jacobs, 1975 the F antigen as ferritin by the same group of workers (Eshhar, Order and Katz, 1974) . We should like to emphasize the importance of specific characterization of proteins where this is possible, rather than reliance on electrophoretic mobility or any other single feature for identification. 
